SkinHealth Systems Inc. (SKIN)
SKIN trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/0001628280-26-017376-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | SKIN on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001818093 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $300.8M |
| Net income | -$9.5M |
| Operating income | -$20.8M |
| Net margin | -3.2% |
| Operating margin | -6.9% |
| Revenue growth | -10.0% |
| Cash | $232.7M |
| Total assets | $499.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.3× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-05 |
| Cash and burn | $112.4M cash; operating cash flow $5.9M a quarter. | Report 2026-09-30 |
| Shares outstanding | 6,542,468 (2026-11-02); 127,503,059 a year earlier; 131,266,839 three years earlier. 1y figure adjusted for split (1-for-20 overall); 3y figure adjusted for split (1-for-20 overall). | Cover page 2026-11-02 |
| Reverse splits, 3 years | 1; latest 1-for-20 on 2026-10-14 | Source 2026-10-14 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | 1 (8-K item 3.01) | 8-K 2026-05-12 |
| Auditor | Deloitte & Touche LLP, Los Angeles, California, United States | PCAOB Form AP 2026-03-23 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $69.2M | -$888K | $11.3M | $112.4M | $243.0M | $288.6M | 10-Q 2026-11-05 |
| Q2 2026 2026-06-30 | $72.1M | -$2.7M | $2.7M | $206.1M | $345.2M | $290.0M | 10-Q 2026-08-06 |
| Q1 2026 2026-03-31 | $64.9M | -$6.6M | -$5.6M | $204.4M | $344.2M | $296.1M | 10-Q 2026-05-07 |
| Q4 2025 2025-12-31 | $82.4M | -$8.1M | $15.2M | $232.7M | $364.4M | $300.8M | 10-K 2026-03-12 |
| Q3 2025 2025-09-30 | $70.7M | -$11.0M | $9.6M | $219.4M | $363.4M | $301.9M | 10-Q 2026-11-05 |
| Q2 2025 2025-06-30 | $78.2M | $19.7M | $9.6M | $212.0M | $363.1M | $310.1M | 10-Q 2026-08-06 |
| Q1 2025 2025-03-31 | $69.6M | -$10.1M | $3.0M | $373.0M | $553.0M | $322.5M | 10-Q 2026-05-07 |
| Q4 2024 2024-12-31 | $83.5M | -$10.3M | $16.5M | $370.1M | $552.2M | $334.3M | 10-K 2026-03-12 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2023-01-13 |
| Latest annual report | 10-K | 2026-03-12 |
| Latest quarterly / interim | 10-Q | 2026-11-05 |
| Latest current report | 8-K | 2026-11-05 |
| Latest proxy ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS | DEFA14A | 2026-08-12 |
Source: SEC EDGAR submissions feed, 442 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +3.8% |
| 1 month | +50.7% |
| 3 months | +23.6% |
| Year to date | +1073.4% |
| 1 year | +1154.6% |
| From 52-week high | -47.7% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SKYA | SkyAI Inc. | $2.11 | -9.05% | $107.3M |
| NYXH | Nyxoah SA | $0.8937 | -0.64% | $89.4M |
| APYX | Apyx Medical Corporation | $2.65 | -5.69% | $111.6M |
| LUCD | Lucid Diagnostics Inc. | $0.3978 | -11.42% | $82.3M |
| STIM | Neuronetics Inc. | $1.25 | -10.07% | $120.6M |
| LUNG | Pulmonx Corporation | $2.80 | -2.10% | $121.9M |
| PYPD | PolyPid Ltd. | $6.15 | -1.76% | $124.9M |
| LNSR | LENSAR Inc. | $5.29 | +5.80% | $65.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier